3α,21-Dihydroxy-5α-pregnane-11,20-dione
CAS: 14107-37-0
Ref. 3D-FD17323
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued |
Product Information
Name:
3α,21-Dihydroxy-5α-pregnane-11,20-dione
Controlled Product
Synonyms:
- (3α,5α)-3,21-Dihydroxypregnane-11,20-dioneAlphadolone
- (3Α,5Α)-3,21-Dihydroxypregnane-11,20-Dione
- 3-alpha,21-Dihydroxy-5-alpha-pregnane-11,20-dione
- 3alpha,21-Dihydroxy-5alpha-pregnane-11,20-dione
- 5-alpha-Pregnane-11,20-dione, 3-alpha,21-dihydroxy-
- 5α-Pregnane-11,20-dione, 3α,21-dihydroxy-
- 5α-Pregnane-3α,21-diol-11,20-dione
- Alfadolona
- Alfadolona [INN-Spanish]
- Alfadolone [INN:DCF]
- See more synonyms
- Alfadolonum
- Alfadolonum [INN-Latin]
- Alphadolone
- Gr 2/1574
- Pregnane-11,20-dione, 3,21-dihydroxy-, (3α,5α)-
- Unii-Oe1C96974E
- Alfadolone
Description:
3a,21-Dihydroxy-5a-pregnane-11,20-dione (3A,21P) is a nitrous oxide metabolite produced by the enzyme cytochrome P450. It has been shown to have low potency as an anaesthetic and to have a clinical relevance in the treatment of postoperative pain. 3A,21P has been found to be antinociceptive in animal models and may act through the gamma-aminobutyric acid system. It is also involved in neuronal function and polymorphonuclear leucocytes. 3A,21P is not currently used clinically for any indication. The mechanism of action for this molecule is not known with certainty but it may inhibit the formation of prostaglandins or increase sensitivity to GABA receptors.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
348.48 g/mol
Formula:
C21H32O4
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
